logo

Synergy Pharmaceuticals, Inc. (SGYP)



Trade SGYP now with
  Date
  Headline
8/7/2018 6:07:12 AM Synergy Pharma Unveils License Deal With Luoxin Pharma For TRULANCE In China
1/25/2018 6:03:18 AM Synergy Pharma Announces FDA Approval Of TRULANCEĀ® For IBS-C In Adults
12/19/2017 9:03:12 AM Synergy Pharma Names Troy Hamilton CEO, Effective Immediately
9/5/2017 8:35:40 AM Synergy Pharma Secures $300 Mln Debt Financing
8/9/2017 4:33:30 PM Synergy Pharma Q2 Loss Per Share $0.33 Vs Loss $0.23 Last Year
6/7/2017 9:08:19 AM Synergy Pharma Announces Acceptance Of SNDA For TRULANCE For Treatment Of Adults With IBS-C
5/7/2017 10:43:09 AM Synergy To Present TRULANCE Phase 3 Data At DDW For Treatment Of Adults With CIC With Moderate To Very Severe Bloating
4/17/2017 8:04:01 AM Synergy Pharma Names Gary Gemignani CFO, Effective April 17
4/12/2017 8:22:26 AM Synergy Pharma Announces Issuance Of Three New Patents Expected To Extend TRULANCE Patent Protection Until 2032
3/27/2017 8:07:30 AM Synergy Pharma Submits Supplemental NDA For TRULANCE For Irritable Bowel Syndrome With Constipation